Pharma

Pharma

In appeal, Advanz calls UK fine 'manifestly wrong'

In an appeal of its fine from the government for the pricing of a thyroid medicine, Advanz called the action of the government "quasi-criminal."
Kevin Dunleavy Sep 27, 2022 3:48pm

Eli Lilly sued by US agency for age discrimination

Sep 27, 2022 11:25am

Many Vendors or One Partner?

Sep 26, 2022 8:00am

Santen and UBE gain FDA approval for Omlonti eye drops

Sep 27, 2022 10:23am

Biogen finalizes $900M MS kickback suit settlement

Sep 27, 2022 9:56am

Asymchem Labs in early planning for $697M manufacturing facility

Sep 27, 2022 9:51am